EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›GNW

GNW

GENWORTH FINANCIAL INC

Next earnings Jul 28, 2026 · consensus $0.10 EPS

Last earnings +0.0% on 2026-05-05

Hold
$9.46
▲ +0.64%
$9.46▲ +19.90%
over 1Y
L $7.26EODHDH $9.46
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.6%
1W+5.8%
1M+7.0%
3M+18.4%
YTD+5.5%
1Y+19.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Overvalued
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 6 analysts
Buy

Cheap on price/sales with aggressive buybacks, but earnings quality is deteriorating and ROE is anemic — a value trap risk.

Price $9.29 · current

The read

Middling fundamentals and a rich price (~59% above fair value) leave little margin of safety — a wait-and-see.

Genworth is a tale of two stories sitting at an uncomfortable middle. The headline valuation looks compelling: 0.5x P/S, a $3.60B market cap against $8.75B of book equity (roughly 0.41x P/B implied), and management is shrinking the share count aggressively — shares outstanding fell 7.5% YoY and the company spent $247M on buybacks in FY2025 (up 30.7%). Retained earnings are climbing (+15.2% to $1.68B), and operating cash flow rebounded sharply to $327M (+271.6%). For a sub-$10 stock trading well below book, that buyback cadence is the most tangible bull case.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$7.82B$7.50B$7.49B$7.29B$7.30B
Gross profit—————
Operating income$474M$818M$41.0M——
Net income$850M$916M$76.0M$299M$223M
Diluted EPS$1.65$1.79$0.16$0.68$0.54
Net margin10.9%12.2%1.0%4.1%3.1%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield6.1%
FCF yield—

Quality & risk

ROIC (est.)0.3%
Free cash flow—
Total debt$2.44B
Net cash-$407M
Piotroski F-Score5/7

Capital returns

Buyback yield6.7%
Dividend yield (est.)0.0%
Shareholder yield6.7%
Shares Δ YoY-7.5%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Shareholder vote2026-05-21

    Annual meeting vote results; directors elected and routine governance items approved

  2. 10-Q Quarterly report2026-05-06

    Q1 2026 10-Q: ongoing buybacks, Enact persistency easing as rates decline

  3. 8-K Earnings results2026-05-05

    Q1 2026 earnings release; Enact steady, buyback program continuing

  4. 10-K Annual report2026-02-27

    FY2025 10-K: Enact loss ratio jumped to 11% from 4%; $247M buybacks, shares -7.5%

  5. 8-K Earnings results2026-02-23

    FY2025 results: net income $223M down 25% YoY, EPS $0.54 vs $0.68

  6. 8-K Earnings results2026-02-03

    Interim financial disclosure ahead of Q4 release; likely Enact capital/special-item update

  7. 10-Q Quarterly report2025-11-06

    Q3 2025 10-Q filing with quarterly financials and Enact segment update

  8. 8-K Earnings results2025-11-05

    Q3 2025 earnings; Enact reserve releases moderating as loss ratio normalizes

  9. 10-Q Quarterly report2025-07-31

    Q2 2025 10-Q; mortgage insurance in-force grew modestly amid rate volatility

Recent filings

all on EDGAR ↗
11-KPeriod ending 2025-12-312026-06-18open ↗4Period ending 2026-05-272026-05-28open ↗4Period ending 2026-05-222026-05-27open ↗4Period ending 2026-05-222026-05-26open ↗4Period ending 2026-05-212026-05-22open ↗144Filing2026-05-22open ↗144Filing2026-05-22open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueA
GrowthF
ProfitabilityD
Financial healthA-
Momentum—
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$3.92

Overvalued -59% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.54 × (8.5 + 1.5 × 0.0% growth) × 0.85 quality = 7.3× multiple. An estimate, not a price target.

Revenue
$7.30B
+0.1% YoY
Net margin
3.1%
ROE
2.5%
P/E
17.5

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$7.30B+0.1%
Net income$223M-25.4%
Operating income$41.0M-95.0%
Diluted EPS$0.54-20.6%
Cash & equivalents$2.04B-0.6%
Total assets$88.1B+1.5%
Total liabilities$78.3B+1.1%
Stockholders' equity$8.75B+3.6%
Op.: 0.6%L/E: 8.95x

Frequently asked

Is GENWORTH FINANCIAL INC (GNW) a buy?
GNW currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Cheap on price/sales with aggressive buybacks, but earnings quality is deteriorating and ROE is anemic — a value trap risk.
What is GNW's fair value?
A Modified-Graham model based on GNW's SEC fundamentals estimates a fair value of about $3.92. It is an estimate from reported earnings, not a price target.
Is GNW overvalued or undervalued?
Against a Modified-Graham fair-value estimate, GNW currently appears overvalued relative to its SEC-grounded earnings power.
What is GENWORTH FINANCIAL INC's quality score?
GNW scores 60.882352941176464/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001276520, latest 10-Q filed 2026-05-06) · EODHD · analysis by claude-code · as of 6/25/2026, 1:26:22 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 2 sales

2026-05-27
McInerney Thomas J
President and CEO; Director
Gift200K
2026-05-22
McInerney Thomas J
President and CEO; Director
Sell100K @ $9.27$927K
2026-05-22
RESTREPO ROBERT P JR
Director
Sell50.0K @ $9.12$456K
2026-05-21
Taylor Morris C.
EVP & CIO
Exercise21.5K
2026-05-21
Taylor Morris C.
EVP & CIO
Tax6.48K @ $9.19$59.5K
2026-05-20
Van Wyk Steven C.
Director
Award32.1K @ $9.03$290K
2026-05-20
Smith Ramsey D.
Director
Award18.3K @ $9.03$165K
2026-05-20
Sarsynski Elaine A
Director
Award32.1K @ $9.03$290K
2026-05-20
RESTREPO ROBERT P JR
Director
Award18.3K @ $9.03$165K

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2008-10-08
Last amount
$0.10
ex 2008-10-08paid 2008-10-27$0.10
ex 2008-07-09paid 2008-07-28$0.10
ex 2008-04-09paid 2008-04-28$0.10
ex 2008-01-09paid 2008-01-28$0.10
ex 2007-10-10paid 2007-10-29$0.10
ex 2007-07-10paid 2007-07-27$0.09

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-05Miss -41.2% est▲ 0.00%8-K ↗
2026-02-23Miss -91.7% est▼ -5.47%8-K ↗
2026-02-03Miss -91.7% est▲ +0.35%8-K ↗
2025-11-05Beat +454.5% est▲ +0.47%8-K ↗
2025-07-30Beat +13.7% est▼ -0.88%8-K ↗
2025-04-30—▼ -0.15%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2025-08-13Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
TheKey and CareScout Surpass 500 Families Supported Through Person-Centered National Home Care PartnershipBullish
finance.yahoo.com· 2026-06-17
Genworth Financial (GNW) Earns Another Vote of Confidence as Outlook BrightensBullish
finance.yahoo.com· 2026-06-12
Genworth Financial Announces Results of Annual MeetingBullish
finance.yahoo.com· 2026-05-20
Will Genworth's (GNW) Softer Q1 Results and Buybacks Reframe Its Capital Allocation Narrative?Bullish
finance.yahoo.com· 2026-05-11
Genworth Financial Q1 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-05-10
Genworth (GNW) Q1 2026 Earnings TranscriptBullish
finance.yahoo.com· 2026-05-06

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score61 vs 67
Revenue growth0.1% vs 7.1%
Net margin3.1% vs 10.5%
Return on equity2.5% vs 12.3%
P/E17.5 vs 25.5

News sentiment

EODHD · 7d
Bullish
+0.17
vs typical · 7 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.